Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Brander

Showing results (1-10 of 51) with videos related to

Pageof 6
Sort By:
Current Opinion in Microbiology|September 6, 2000
Modulation of host immune responses by clinically relevant human DNA and RNA virusesC Brander, B D Walker
Current Opinion in Immunology|August 17, 1999
T lymphocyte responses in HIV-1 infection: implications for vaccine developmentC Brander, B D Walker
Clinical and Experimental Immunology|July 1, 1995
Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccineC Brander, W J Pichler, G Corradin
Therapeutische Umschau. Revue Therapeutique|November 10, 2005
[HIV-1 vaccination--is there hope?]R F Speck, C Brander, T M Kündig
Clinical and Experimental Immunology|July 1, 1996
Peptide immunization in humans: a combined CD8+/CD4+ T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes (CTL)C Brander, G Corradin, T Hasler, et al.
The Veterinary Record|October 18, 1975
A large scale mastitis control programme in SomersetG C Brander, J H Watkins, R P Gard
Current Medicinal Chemistry|August 10, 2011
Immune correlates of HIV controlJ G Prado, J Carrillo, J Blanco-Heredia, et al.
European Journal of Immunology|September 1, 1992
Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cellsT Wyss-Coray, C Brander, K Frutig, et al.
Cellular Immunology|October 1, 1994
Improved sensitization of antigen-presenting cells with transferrin-bound peptides: advantages in competition for antigen presentationD Mauri, T Wyss-Coray, C Brander, et al.
European Journal of Immunology|December 1, 1993
Carrier-mediated uptake and presentation of a major histocompatibility complex class I-restricted peptideC Brander, T Wyss-Coray, D Mauri, et al.
Pageof 6

Showing results (1-10 of 51) with videos related to

Sort By:
Pageof 6
Current Opinion in Microbiology|September 6, 2000
Modulation of host immune responses by clinically relevant human DNA and RNA virusesC Brander, B D Walker
Current Opinion in Immunology|August 17, 1999
T lymphocyte responses in HIV-1 infection: implications for vaccine developmentC Brander, B D Walker
Clinical and Experimental Immunology|July 1, 1995
Identification of HIV protein-derived cytotoxic T lymphocyte (CTL) epitopes for their possible use as synthetic vaccineC Brander, W J Pichler, G Corradin
Therapeutische Umschau. Revue Therapeutique|November 10, 2005
[HIV-1 vaccination--is there hope?]R F Speck, C Brander, T M Kündig
Clinical and Experimental Immunology|July 1, 1996
Peptide immunization in humans: a combined CD8+/CD4+ T cell-targeted vaccine restimulates the memory CD4 T cell response but fails to induce cytotoxic T lymphocytes (CTL)C Brander, G Corradin, T Hasler, et al.
The Veterinary Record|October 18, 1975
A large scale mastitis control programme in SomersetG C Brander, J H Watkins, R P Gard
Current Medicinal Chemistry|August 10, 2011
Immune correlates of HIV controlJ G Prado, J Carrillo, J Blanco-Heredia, et al.
European Journal of Immunology|September 1, 1992
Discrimination of human CD4 T cell clones based on their reactivity with antigen-presenting T cellsT Wyss-Coray, C Brander, K Frutig, et al.
Cellular Immunology|October 1, 1994
Improved sensitization of antigen-presenting cells with transferrin-bound peptides: advantages in competition for antigen presentationD Mauri, T Wyss-Coray, C Brander, et al.
European Journal of Immunology|December 1, 1993
Carrier-mediated uptake and presentation of a major histocompatibility complex class I-restricted peptideC Brander, T Wyss-Coray, D Mauri, et al.
Pageof 6